To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC9687 | WST-8 Featured |
WST-8 is a next generation tetrazolium reagent that serves as a sensitive chromogenic indicator for NADH.
More description
|
|
| DC4207 | Fondaparinux sodium Featured |
Fondaparinux sodium is a synthetic and specific inhibitor of activated Factor X (Xa).
More description
|
|
| DC9440 | Estropipate Featured |
Estropipate is a form of estrogen, used to treat symptoms of menopause, also used to prevent osteoporosis.
More description
|
|
| DC9120 | Miltefosine Featured |
Miltefosine is an alkylphosphocholine drug.
More description
|
|
| DC4190 | Fludarabine phosphate Featured |
Fludarabine Phosphate is an analogue of adenosine and deoxyadenosine, which is able to compete with dATP for incorporation into DNA and inhibit DNA synthesis.
More description
|
|
| DC31242 | GS 9219 Featured |
GS-9219 is a prodrug of the acyclic nucleoside phosphonate analogue 9-(2-phosphonylmethoxyethyl)guanine (PMEG) with potential antineoplastic activity. Formulated to selectively accumulate in lymphocytes, nucleotide analogue GS 9219 is converted to its active metabolite, PMEG diphosphate (PMEGpp), via enzymatic hydrolysis, deamination, and phosphorylation; subsequently, PMEGpp is incorporated into nascent DNA chains by DNA polymerases, which may result in the termination of DNA synthesis, S-phase cell cycle arrest, and the induction of apoptosis in susceptible lymphoma cell populations.
More description
|
|
| DC24187 | Calcifediol monohydrate Featured |
The major circulating metabolite of vitamin D3.
More description
|
|
| DC23292 | Necrox-5 methanesulfonate Featured |
NecroX-5 is a novel necroptosis inhibitor that reduces mitochondrial oxidative stress, prevents hypoxia/reoxygenation injury by inhibiting the mitochondrial calcium uniporter.
More description
|
|
| DCAPI1037 | Gadodiamide (Omniscan) Featured |
Gadodiamide is a gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. Target: OthersGadodiamide(Omniscan) is a gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. Gadodiamide is a contrast medium for cranial and spinal magnetic resonance imaging (MRI) and for general MRI of the body after intravenous administration. The product provides contrast enhancement and facilitates visualisation of abnormal structures or lesions in various parts of the body including the central nervous system (CNS). A recent review takes the question of toxicity caused by loss of gadolinium from the complex. "The challenge for nephrologists includes (a) evidence of transmetallation, such as gadolinium deposits in bone, increased urinary zinc excretion, iron-transferrin dissociation or 'spurious hypocalcemia' in exposed people"。
More description
|
|
| DC7805 | CID 121433863 Featured |
GS-7340(Tenofovir alafenamide) is a prodrug of tenofovir (TFV) that more efficiently delivers TFV into lymphoid cells and tissues than TFV disoproxil fumarate.
More description
|
|
| DC31494 | GS-7340 (fumarate) Featured |
Tenofovir alafenamide, also known as TAF and GS-7340, is a nucleotide reverse transcriptase inhibitor (NRTIs) and a novel prodrug of tenofovir. By blocking reverse transcriptase, TAF prevent HIV from multiplying and can reduce the amount of HIV in the body. Tenofovir alafenamide is a prodrug, which means that it is an inactive drug. In the body, tenofovir alafenamide is converted to tenofovir diphosphate (TFV-DP). Tenofovir alafenamide fumarate was approved in November 2015 for treatment of HIV-1.
More description
|
|
| DCAPI1064 | mixtures of three isomers (Gentamicins C1, C2, and C1(subA). Featured |
Gentamycin sulfate (Gentacycol)
More description
|
|
| DCC5678 | Zyz-803 |
Novel slow H2S-NO-releasing hybrid, attenuating cardiac dysfunction after heart failure
More description
|
|
| DCC5677 | Zyj-34v |
Oral active histone deacetylase inhibitor with potent antitumor activity
More description
|
|
| DCC5676 | Zyj-34c |
Novel histone deacetylase inhibitor (HDACi) with potent oral antitumor activities
More description
|
|
| DCC5675 | Zyj-25e |
Novel histone deacetylase inhibitor (HDACi) with potent oral antitumor activities
More description
|
|
| DCC5674 | Zydpla1 |
Novel next generation orally active DPP-4 inhibitor to treat Type 2 Diabetes
More description
|
|
| DCC5673 | Zxx2-77 |
Cyclooxygenase-1 inhibitor
More description
|
|
| DCC5672 | Zx-j-19l |
Novel inhibitor of Cyclophilin J (CyPJ) PPIase, demonstrating remarkable inhibition of tumor cell growth, comparable to CsA but much stronger than 5-fluorouracil
More description
|
|
| DCC5671 | Zx-j-19j |
Novel inhibitor of Cyclophilin J (CyPJ) PPIase, demonstrating remarkable inhibition of tumor cell growth, comparable to CsA but much stronger than 5-fluorouracil
More description
|
|
| DCC5669 | Zwm026 |
Novel multi-target inhibitor, harboring selectivity of inhibiting EGFR T790M sparing wild-type EGFR
More description
|
|
| DCC5668 | Zwittermicin A |
Natural antibiotic, having diverse biological activities including broad-spectrum antibiosis against Bacteria and lower Eukarya, plant disease suppression, and enhancement of the insecticidal activity of Bacillus thuringiensis toxin against lepidopteran l
More description
|
|
| DCC5667 | Z-wehd-fmk |
Potent, cell-permeable and irreversible caspase-1/5 inhibitor
More description
|
|
| DCC5666 | Zuclopenthixol Dihydrochloride |
Antagonist of D1 and D2 dopamine receptors.
More description
|
|
| DCC5665 | Zu-4280011 |
Novel COX-2 inhibitor
More description
|
|
| DCC5664 | Ztz240 |
Novel potentiator of KCNQ2 potassium channels
More description
|
|
| DCC5663 | Ztb23(r) |
The first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor
More description
|
|
| DCC5662 | Zp1-12cl |
Novel zinc sensor with a chloroalkane linker, reacting specifically with the engineered protein HaloTag, binding zinc ions with a threefold fluorescence enhancement
More description
|
|
| DCC5661 | Zolimidine |
Gastroprotective agent for the treatment of peptic ulcer
More description
|
|
| DCC5660 | Zoledronate Disodium |
Inhibitor of osteoclastogenesis and macrophage recruitment, decreasing bone turnover and stabilizing the bone matrix, exhibiting diverse anti-tumor effects in osteosarcoma
More description
|
|